Tim A. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tim A. White has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Dawn Reid White
National University
10 shared publications - Melanie M. Tidman
Liberty University
8 shared publications Adrian Swart
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
1 shared publication- Bronson Dant
BD Solutions LLC
1 shared publication Eric W. Hickey
Walden University, School of Psychology, Minneapolis, MN, USA
1 shared publication- Henry M. Walker
Kaiser Foundation Hospital
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 12
Effects of three nutritional approaches on metabolic health and Parkinson’s disease: A 32-week crossover study
Background: Parkinson’s disease (PD) is a neurodegenerative disorder with motor and non-motor symptoms that impair quality of life. Altered neuronal glucose metabolism may contribute to PD symptoms, suggesting a potential role for nutritional interventions. Aim: To examine three dietary approaches in relation to PD symptoms, sleep, fatigue, cognition, and metabolic biomarkers. Setting: This 32-week, fully virtual crossover study recruited participants across the United States. Interventions, assessments, and monitoring were completed remotely. Methods: Sixteen participants completed three 8-week dietary phases separated by 4-week washouts. Glucose and ketones were monitored during Phases II and III. Laboratory measures were obtained at baseline and after each phase. Standardised PD scales, exit surveys, adherence and interviews assessed outcomes and participant experiences. Results: Body weight and glycated haemoglobin improved significantly during the low-carbohydrate ketogenic diet plus medium-chain triglyceride (MCT) oil phase. Changes in PD-specific scale scores were not statistically significant. Participants qualitatively reported improvements in energy, cognitive clarity, sleep, and selected PD symptoms. Conclusion: A low-carbohydrate ketogenic diet with MCT oil may improve metabolic outcomes and selected patient-perceived symptoms in PD. Adherence and gastrointestinal intolerance may affect long-term feasibility. Contribution: This study provides preliminary evidence on nutritional interventions, metabolic health, and PD-related symptoms. It also demonstrates the feasibility of remote nutritional research using telehealth, home monitoring, and standardised PD scales. Larger controlled trials are needed to determine whether metabolic improvements translate into clinically meaningful PD outcomes.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 12
Open AccessEffects of three nutritional approaches on metabolic health and Parkinson’s disease: A 32-week crossover study
Background: Parkinson’s disease (PD) is a neurodegenerative disorder with motor and non-motor symptoms that impair quality of life. Altered neuronal glucose metabolism may contribute to PD symptoms, suggesting a potential role for nutritional interventions. Aim: To examine three dietary approaches in relation to PD symptoms, sleep, fatigue, cognition, and metabolic biomarkers. Setting: This 32-week, fully virtual crossover study recruited participants across the United States. Interventions, assessments, and monitoring were completed remotely. Methods: Sixteen participants completed three 8-week dietary phases separated by 4-week washouts. Glucose and ketones were monitored during Phases II and III. Laboratory measures were obtained at baseline and after each phase. Standardised PD scales, exit surveys, adherence and interviews assessed outcomes and participant experiences. Results: Body weight and glycated haemoglobin improved significantly during the low-carbohydrate ketogenic diet plus medium-chain triglyceride (MCT) oil phase. Changes in PD-specific scale scores were not statistically significant. Participants qualitatively reported improvements in energy, cognitive clarity, sleep, and selected PD symptoms. Conclusion: A low-carbohydrate ketogenic diet with MCT oil may improve metabolic outcomes and selected patient-perceived symptoms in PD. Adherence and gastrointestinal intolerance may affect long-term feasibility. Contribution: This study provides preliminary evidence on nutritional interventions, metabolic health, and PD-related symptoms. It also demonstrates the feasibility of remote nutritional research using telehealth, home monitoring, and standardised PD scales. Larger controlled trials are needed to determine whether metabolic improvements translate into clinically meaningful PD outcomes.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 6
Targeting insulin and leptin in obesity management: A case series in metabolic health practice
A low-carbohydrate ketogenic (LCK) diet implemented in a metabolic health practice was evaluated for its association with changes in fasting hyperinsulinemia, fasting hyperleptinemia and other metabolic biomarkers in adults with obesity. Six adults with obesity were recruited from the Duly Weight Loss Clinic in Westmont, Illinois, between 2022 and 2025. The cohort comprised three men and three women with a body mass index (BMI) > 30 kg/m2 who followed an LCK diet without anti-obesity pharmacotherapy. Participants were monitored for 12 months with visits every 30–60 days that included counselling, coaching and fasting beta-hydroxybutyrate checks. Outcomes measured were changes in body weight, fasting insulin, fasting leptin and haemoglobin A1c (HbA1c). All six participants achieved clinically meaningful weight loss over 12 months. Mean weight reduction was 25% from baseline. Fasting insulin decreased by a mean of 15.3 mIU/L, representing a 64% reduction. Fasting leptin decreased by a mean of 25.5 ng/mL, corresponding to an 80% reduction. Haemoglobin A1c decreased by a mean of 0.27%. Weight reduction was accompanied by reductions in fasting insulin and fasting leptin, while HbA1c remained relatively stable. An LCK dietary approach combined with structured lifestyle support was associated with substantial weight loss and reductions in fasting insulin and circulating leptin, with HbA1c remaining relatively stable over 12 months. These findings support further investigation of an LCK diet within structured outpatient obesity management. An LCK diet within a structured obesity medicine programme was associated with clinically meaningful weight loss and reductions in fasting insulin and leptin concentrations.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 6
Open AccessTargeting insulin and leptin in obesity management: A case series in metabolic health practice
A low-carbohydrate ketogenic (LCK) diet implemented in a metabolic health practice was evaluated for its association with changes in fasting hyperinsulinemia, fasting hyperleptinemia and other metabolic biomarkers in adults with obesity. Six adults with obesity were recruited from the Duly Weight Loss Clinic in Westmont, Illinois, between 2022 and 2025. The cohort comprised three men and three women with a body mass index (BMI) > 30 kg/m2 who followed an LCK diet without anti-obesity pharmacotherapy. Participants were monitored for 12 months with visits every 30–60 days that included counselling, coaching and fasting beta-hydroxybutyrate checks. Outcomes measured were changes in body weight, fasting insulin, fasting leptin and haemoglobin A1c (HbA1c). All six participants achieved clinically meaningful weight loss over 12 months. Mean weight reduction was 25% from baseline. Fasting insulin decreased by a mean of 15.3 mIU/L, representing a 64% reduction. Fasting leptin decreased by a mean of 25.5 ng/mL, corresponding to an 80% reduction. Haemoglobin A1c decreased by a mean of 0.27%. Weight reduction was accompanied by reductions in fasting insulin and fasting leptin, while HbA1c remained relatively stable. An LCK dietary approach combined with structured lifestyle support was associated with substantial weight loss and reductions in fasting insulin and circulating leptin, with HbA1c remaining relatively stable over 12 months. These findings support further investigation of an LCK diet within structured outpatient obesity management. An LCK diet within a structured obesity medicine programme was associated with clinically meaningful weight loss and reductions in fasting insulin and leptin concentrations.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 10
How the ketogenic diet affects patients with Parkinson’s disease: A descriptive phenomenological study
Background: For individuals living with Parkinson’s disease (PD), the earliest and most disruptive changes are often not tremor or rigidity, but a gradual loss of mental clarity, physical confidence and social ease that reshapes everyday life. Aim: To explore how individuals with PD described changes in mental, physical and social quality of life (QoL) before and after participating in a 12-week low-carbohydrate, healthy-fat ketogenic dietary intervention. Setting: The study setting consisted of participants recruited through the Colorado Parkinson Foundation, a community-based organisation supporting individuals living with Parkinson’s disease and their caregivers. All participants resided in the United States during the study period. Methods: Sixteen adults diagnosed with PD, aged 36–81 years, participated in this descriptive phenomenological study. Participants were recruited with assistance from the Colorado Parkinson Foundation and resided in the United States. Semi-structured interviews were conducted via Zoom before and after the dietary intervention to capture participants’ lived experiences across time. Results: Pre-study interviews yielded three major themes describing participants’ experiences prior to dietary change, while post-study interviews yielded four major themes reflecting experiences following completion of the intervention. Participants described changes related to mental clarity, physical function, social engagement, metabolic health and relational support. Conclusion: Findings highlight how metabolic-based dietary intervention was experienced in everyday life by individuals living with PD. Participants described improvements in mental clarity, physical function and social engagement that corresponded to observed changes in metabolic health, suggesting a meaningful connection between metabolic adaptation and QoL. Contribution: Centring participant perspectives provides important patient-centred insight into how metabolic changes associated with a ketogenic diet (KD) intervention are experienced and integrated into QoL beyond clinical or biomarker outcomes.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 10
Open AccessHow the ketogenic diet affects patients with Parkinson’s disease: A descriptive phenomenological study
Background: For individuals living with Parkinson’s disease (PD), the earliest and most disruptive changes are often not tremor or rigidity, but a gradual loss of mental clarity, physical confidence and social ease that reshapes everyday life. Aim: To explore how individuals with PD described changes in mental, physical and social quality of life (QoL) before and after participating in a 12-week low-carbohydrate, healthy-fat ketogenic dietary intervention. Setting: The study setting consisted of participants recruited through the Colorado Parkinson Foundation, a community-based organisation supporting individuals living with Parkinson’s disease and their caregivers. All participants resided in the United States during the study period. Methods: Sixteen adults diagnosed with PD, aged 36–81 years, participated in this descriptive phenomenological study. Participants were recruited with assistance from the Colorado Parkinson Foundation and resided in the United States. Semi-structured interviews were conducted via Zoom before and after the dietary intervention to capture participants’ lived experiences across time. Results: Pre-study interviews yielded three major themes describing participants’ experiences prior to dietary change, while post-study interviews yielded four major themes reflecting experiences following completion of the intervention. Participants described changes related to mental clarity, physical function, social engagement, metabolic health and relational support. Conclusion: Findings highlight how metabolic-based dietary intervention was experienced in everyday life by individuals living with PD. Participants described improvements in mental clarity, physical function and social engagement that corresponded to observed changes in metabolic health, suggesting a meaningful connection between metabolic adaptation and QoL. Contribution: Centring participant perspectives provides important patient-centred insight into how metabolic changes associated with a ketogenic diet (KD) intervention are experienced and integrated into QoL beyond clinical or biomarker outcomes.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 7
Low-carb nutrition education for metabolic health in veterans: A Veterans Affair clinical audit
Background: United States (US) veterans face high rates of obesity and type 2 diabetes (T2D), with traditional interventions like VA MOVE! achieving limited success. Non-prescriptive low-carbohydrate (LC) nutrition education may offer a scalable alternative but remains under-evaluated. Aim: To describe metabolic outcomes observed following the introduction of informal LC nutrition education among veterans with obesity, prediabetes or T2D in a rural Veterans Affair (VA) primary care clinic. Setting: This clinical audit was conducted in a rural Veterans Affairs primary care clinic at the Martinsburg Veterans Administration Medical Center, where LC nutrition education was delivered during routine care visits without structured programming or additional clinical resources. Methods: A retrospective audit at the Martinsburg Veterans Administration Medical Centre included 481 veterans with obesity, prediabetes or T2D who received informal LC education during a routine primary care visit. No structured protocol was used. Metabolic markers were measured at baseline and at the final visit, with an average of 10 months later. All eligible patients receiving education were included. Results: Following introduction of the LC education approach, there was a statistically significant reduction in hemoglobin A1c (HbA1c) and weight, as well as discontinuation or reduction of insulin in 23 or 38 insulin-using veterans and of non-insulin glucose-lowering medications in 45 of 123 veterans. These reductions occurred in the context of an average 10-pound weight loss and a mean HbA1c reduction of 0.43% in those with prediabetes or T2D. Additionally, there was a statistically significant reduction in diastolic blood pressure (BP), triglycerides and the triglyceride-to-high-density lipoprotein (HDL) ratio, along with a 4.2-point increase in HDL cholesterol. Discussion: Observed improvements in metabolic markers and medication use suggest that informal LC education may be a promising low-burden approach within primary care settings. Larger randomised trials are needed to assess scalability and long-term outcomes. Conclusion: Informal low-carbohydrate nutrition education may represent a feasible and scalable approach to improving metabolic health and reducing medication burden among veterans. Further controlled studies are needed to confirm these findings and assess long-term outcomes, adherence, and generalisability.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 7
Open AccessLow-carb nutrition education for metabolic health in veterans: A Veterans Affair clinical audit
Background: United States (US) veterans face high rates of obesity and type 2 diabetes (T2D), with traditional interventions like VA MOVE! achieving limited success. Non-prescriptive low-carbohydrate (LC) nutrition education may offer a scalable alternative but remains under-evaluated. Aim: To describe metabolic outcomes observed following the introduction of informal LC nutrition education among veterans with obesity, prediabetes or T2D in a rural Veterans Affair (VA) primary care clinic. Setting: This clinical audit was conducted in a rural Veterans Affairs primary care clinic at the Martinsburg Veterans Administration Medical Center, where LC nutrition education was delivered during routine care visits without structured programming or additional clinical resources. Methods: A retrospective audit at the Martinsburg Veterans Administration Medical Centre included 481 veterans with obesity, prediabetes or T2D who received informal LC education during a routine primary care visit. No structured protocol was used. Metabolic markers were measured at baseline and at the final visit, with an average of 10 months later. All eligible patients receiving education were included. Results: Following introduction of the LC education approach, there was a statistically significant reduction in hemoglobin A1c (HbA1c) and weight, as well as discontinuation or reduction of insulin in 23 or 38 insulin-using veterans and of non-insulin glucose-lowering medications in 45 of 123 veterans. These reductions occurred in the context of an average 10-pound weight loss and a mean HbA1c reduction of 0.43% in those with prediabetes or T2D. Additionally, there was a statistically significant reduction in diastolic blood pressure (BP), triglycerides and the triglyceride-to-high-density lipoprotein (HDL) ratio, along with a 4.2-point increase in HDL cholesterol. Discussion: Observed improvements in metabolic markers and medication use suggest that informal LC education may be a promising low-burden approach within primary care settings. Larger randomised trials are needed to assess scalability and long-term outcomes. Conclusion: Informal low-carbohydrate nutrition education may represent a feasible and scalable approach to improving metabolic health and reducing medication burden among veterans. Further controlled studies are needed to confirm these findings and assess long-term outcomes, adherence, and generalisability.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 7
Clinical remission of Crohn’s disease symptoms following the adoption of therapeutic carbohydrate reduction: A retrospective single case report
Low-carbohydrate dietary approaches are increasingly explored as adjunctive strategies for Crohn’s disease (CD), particularly in patients who experience limitations or adverse effects with standard biologic therapies. Dietary intervention (DI) may offer a non-pharmacological option to support symptom control and remission. Evidence remains limited, particularly at the individual clinical level. This single-patient, retrospective case report describes an adult with established CD who initiated a therapeutic carbohydrate-restricted diet under clinical guidance. The intervention was implemented as part of ongoing disease management and followed longitudinally during routine care. Clinical outcomes were assessed through symptom patterns, medication use, and sustained follow-up over an extended observation period. Following initiation of the carbohydrate-restricted dietary approach, the patient achieved remission of gastrointestinal symptoms and progressively discontinued pharmacologic therapy. Symptom recurrence was temporally associated with lapses in dietary adherence and resolved promptly upon resumption of the intervention. Sustained adherence was related to continued symptom control and medication independence throughout follow-up. This case suggests that therapeutic carbohydrate reduction may support remission and medication discontinuation in select individuals with CD. The findings underscore the need for controlled clinical trials to evaluate the safety, durability and generalisability of DIs in inflammatory bowel disease. Dietary strategies may represent a complementary avenue for individualised disease management.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 7
Open AccessClinical remission of Crohn’s disease symptoms following the adoption of therapeutic carbohydrate reduction: A retrospective single case report
Low-carbohydrate dietary approaches are increasingly explored as adjunctive strategies for Crohn’s disease (CD), particularly in patients who experience limitations or adverse effects with standard biologic therapies. Dietary intervention (DI) may offer a non-pharmacological option to support symptom control and remission. Evidence remains limited, particularly at the individual clinical level. This single-patient, retrospective case report describes an adult with established CD who initiated a therapeutic carbohydrate-restricted diet under clinical guidance. The intervention was implemented as part of ongoing disease management and followed longitudinally during routine care. Clinical outcomes were assessed through symptom patterns, medication use, and sustained follow-up over an extended observation period. Following initiation of the carbohydrate-restricted dietary approach, the patient achieved remission of gastrointestinal symptoms and progressively discontinued pharmacologic therapy. Symptom recurrence was temporally associated with lapses in dietary adherence and resolved promptly upon resumption of the intervention. Sustained adherence was related to continued symptom control and medication independence throughout follow-up. This case suggests that therapeutic carbohydrate reduction may support remission and medication discontinuation in select individuals with CD. The findings underscore the need for controlled clinical trials to evaluate the safety, durability and generalisability of DIs in inflammatory bowel disease. Dietary strategies may represent a complementary avenue for individualised disease management.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 6
Synergistic management of metabolic syndrome with postmenopausal osteoporosis: A retrospective case report
Metabolic syndrome (MetS) and postmenopausal osteoporosis (POP) commonly coexist, amplifying cardiovascular and fracture risk through shared mechanisms of insulin resistance, inflammation, and impaired energy metabolism. Conventional management often emphasises pharmacotherapy and calcium supplementation, while overlooking the optimisation of metabolic health. Emerging evidence supports nutritional and exercise-based strategies that target both metabolic and skeletal integrity. This study aimed to evaluate the synergistic effects of a low-carbohydrate and ketogenic diet (LCK), resistance training (RT), and bioavailable calcium supplementation on bone mineral density (BMD) and metabolic health in a patient with concurrent POP and MetS. A 65-year-old postmenopausal woman with baseline osteoporosis and MetS provided documentation for a 36-month, three-phase retrospective data analysis. Phase 1 intervention included an LCK (12 months); Phase 2 combined LCK with RT three times per week (12 months); and Phase 3 added daily bioavailable calcium supplementation (12 months). Bone mineral density was assessed via dual-energy X-ray absorptiometry at baseline, 12, 24, and 36 months. Secondary outcomes included metabolic markers, body composition, and inflammatory indices. Progressive increases in BMD T-scores were observed across major skeletal sites. Metabolic outcomes included improved biomarker levels and favourable changes in weight and waist circumference. No adverse effects occurred. Sometimes KD nutrition may not be enough to preserve BMD. The integration of ketogenic nutrition, RT, and calcium supplementation may synergistically enhance BMD while improving metabolic health in individuals with POP and MetS. This multimodal approach represents a promising adjunct to standard management of MetS and osteoporosis and warrants validation through controlled clinical studies.
- 1 January 2026
- Published by AOSIS in Journal of Metabolic Health
- Vol. 9 (1) , 6
Open AccessSynergistic management of metabolic syndrome with postmenopausal osteoporosis: A retrospective case report
Metabolic syndrome (MetS) and postmenopausal osteoporosis (POP) commonly coexist, amplifying cardiovascular and fracture risk through shared mechanisms of insulin resistance, inflammation, and impaired energy metabolism. Conventional management often emphasises pharmacotherapy and calcium supplementation, while overlooking the optimisation of metabolic health. Emerging evidence supports nutritional and exercise-based strategies that target both metabolic and skeletal integrity. This study aimed to evaluate the synergistic effects of a low-carbohydrate and ketogenic diet (LCK), resistance training (RT), and bioavailable calcium supplementation on bone mineral density (BMD) and metabolic health in a patient with concurrent POP and MetS. A 65-year-old postmenopausal woman with baseline osteoporosis and MetS provided documentation for a 36-month, three-phase retrospective data analysis. Phase 1 intervention included an LCK (12 months); Phase 2 combined LCK with RT three times per week (12 months); and Phase 3 added daily bioavailable calcium supplementation (12 months). Bone mineral density was assessed via dual-energy X-ray absorptiometry at baseline, 12, 24, and 36 months. Secondary outcomes included metabolic markers, body composition, and inflammatory indices. Progressive increases in BMD T-scores were observed across major skeletal sites. Metabolic outcomes included improved biomarker levels and favourable changes in weight and waist circumference. No adverse effects occurred. Sometimes KD nutrition may not be enough to preserve BMD. The integration of ketogenic nutrition, RT, and calcium supplementation may synergistically enhance BMD while improving metabolic health in individuals with POP and MetS. This multimodal approach represents a promising adjunct to standard management of MetS and osteoporosis and warrants validation through controlled clinical studies.
- Open Access
- 28 November 2025
- Published by AOSIS in Journal of Metabolic Health
- Vol. 8 (1) , 4
Symposium for metabolic health 2025: Conference report and summary of highlights
The Journal of Metabolic Health is a peer-reviewed, clinically oriented open access journal covering advances in metabolic health and related disorders. The journal focuses on pathophysiology, prevention, management, and advancing therapy for different patient populations with metabolic health issues, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, and other conditions associated with insulin resistance and inflammation. Articles published in the journal will encompass original research with a broad biomedical approach from bench to bedside, including basic research and clinical case studies. In addition, the journal will feature review articles, perspectives, case studies, case reports and editorials to provide comprehensive coverage and critical insights into the field. The content will be of interest to an academic and clinician-based audience, including medical practitioners, clinical educators, dietitians, nutritionists, nurse practitioners, pharmacists, and other healthcare professionals involved in the study and management of metabolic health disorders.
- 28 November 2025
- Published by AOSIS in Journal of Metabolic Health
- Vol. 8 (1) , 4
Open AccessSymposium for metabolic health 2025: Conference report and summary of highlights
The Journal of Metabolic Health is a peer-reviewed, clinically oriented open access journal covering advances in metabolic health and related disorders. The journal focuses on pathophysiology, prevention, management, and advancing therapy for different patient populations with metabolic health issues, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, and other conditions associated with insulin resistance and inflammation. Articles published in the journal will encompass original research with a broad biomedical approach from bench to bedside, including basic research and clinical case studies. In addition, the journal will feature review articles, perspectives, case studies, case reports and editorials to provide comprehensive coverage and critical insights into the field. The content will be of interest to an academic and clinician-based audience, including medical practitioners, clinical educators, dietitians, nutritionists, nurse practitioners, pharmacists, and other healthcare professionals involved in the study and management of metabolic health disorders.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Global Qualitative Nursing Research
- Vol. 12
“The Whole Culture of Nursing Needs to Change”: A Descriptive Phenomenology of Nurses Being Bullied
Workplace bullying impacts at least half of the nurses worldwide. Despite the link to increased nurse turnover, few intervention studies have addressed bullying in the workplace. Since most studies report cross-sectional designs that provide little insight into the complexities of this phenomenon, the purpose of this descriptive phenomenology was to describe the lived experiences of nurses as they were actively being bullied in the workplace. Semi-structured interviews were conducted through Skype until data adequacy was realized with 12 participant interviews. Giorgi’s six-step method was used to analyze the data in Atlas.ti. A central theme, “The whole culture of nursing needs to change” described an organizational culture where managers were unable to identify or unwilling to respond to workplace bullying. The four themes identified from the data included “going to work can be really hard,” “not good for patient care,” “learning to live with bullying,” and “changing the culture.” Leaders of organizations should implement comprehensive anti-bullying programs to assess bullying in their workplace and to provide bullied nurses with reporting options. Nurse managers need to prevent workplace bullying by intervening when aware of bullying and cultivating a culture of mutual respect.
- 1 January 2025
- Published by SAGE Publications in Global Qualitative Nursing Research
- Vol. 12
Open Access“The Whole Culture of Nursing Needs to Change”: A Descriptive Phenomenology of Nurses Being Bullied
Workplace bullying impacts at least half of the nurses worldwide. Despite the link to increased nurse turnover, few intervention studies have addressed bullying in the workplace. Since most studies report cross-sectional designs that provide little insight into the complexities of this phenomenon, the purpose of this descriptive phenomenology was to describe the lived experiences of nurses as they were actively being bullied in the workplace. Semi-structured interviews were conducted through Skype until data adequacy was realized with 12 participant interviews. Giorgi’s six-step method was used to analyze the data in Atlas.ti. A central theme, “The whole culture of nursing needs to change” described an organizational culture where managers were unable to identify or unwilling to respond to workplace bullying. The four themes identified from the data included “going to work can be really hard,” “not good for patient care,” “learning to live with bullying,” and “changing the culture.” Leaders of organizations should implement comprehensive anti-bullying programs to assess bullying in their workplace and to provide bullied nurses with reporting options. Nurse managers need to prevent workplace bullying by intervening when aware of bullying and cultivating a culture of mutual respect.
- Open Access
- 13 June 2024
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 14 (3-4) , 97-110
Impact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a longitudinal study
Aim: Evidence suggests low-carbohydrate diets (LCHF) may assist in treating neurodegenerative diseases such as Parkinson's disease (PD); however, gaps exist in the literature.Patients & methods: We conducted a small 24-week pilot study to investigate the effects of an LCHF diet on motor and nonmotor symptoms, health biomarkers, anxiety, and depression in seven people with PD. We also captured patient experiences during the process (quality of life [QoL]).Results: Participants reported improved biomarkers, enhanced cognition, mood, motor and nonmotor symptoms, and reduced pain and anxiety. Participants felt improvements enhanced their QoL.Conclusion: We conclude that an LCHF intervention is safe, feasible, and potentially effective in mitigating the symptoms of this disorder. However, more extensive randomized controlled studies are needed to create generalizable recommendations.
- 13 June 2024
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 14 (3-4) , 97-110
Open AccessImpact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a longitudinal study
Aim: Evidence suggests low-carbohydrate diets (LCHF) may assist in treating neurodegenerative diseases such as Parkinson's disease (PD); however, gaps exist in the literature.Patients & methods: We conducted a small 24-week pilot study to investigate the effects of an LCHF diet on motor and nonmotor symptoms, health biomarkers, anxiety, and depression in seven people with PD. We also captured patient experiences during the process (quality of life [QoL]).Results: Participants reported improved biomarkers, enhanced cognition, mood, motor and nonmotor symptoms, and reduced pain and anxiety. Participants felt improvements enhanced their QoL.Conclusion: We conclude that an LCHF intervention is safe, feasible, and potentially effective in mitigating the symptoms of this disorder. However, more extensive randomized controlled studies are needed to create generalizable recommendations.
- Open Access
- 21 December 2023
- Published by AOSIS in Journal of Metabolic Health
- Vol. 7 (1) , 4
Symposium for Metabolic Health 2024: Conference report and summary of highlights
The Journal of Metabolic Health is a peer-reviewed, clinically oriented open access journal covering advances in metabolic health and related disorders. The journal focuses on pathophysiology, prevention, management, and advancing therapy for different patient populations with metabolic health issues, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, and other conditions associated with insulin resistance and inflammation. Articles published in the journal will encompass original research with a broad biomedical approach from bench to bedside, including basic research and clinical case studies. In addition, the journal will feature review articles, perspectives, case studies, case reports and editorials to provide comprehensive coverage and critical insights into the field. The content will be of interest to an academic and clinician-based audience, including medical practitioners, clinical educators, dietitians, nutritionists, nurse practitioners, pharmacists, and other healthcare professionals involved in the study and management of metabolic health disorders.
- 21 December 2023
- Published by AOSIS in Journal of Metabolic Health
- Vol. 7 (1) , 4
Open AccessSymposium for Metabolic Health 2024: Conference report and summary of highlights
The Journal of Metabolic Health is a peer-reviewed, clinically oriented open access journal covering advances in metabolic health and related disorders. The journal focuses on pathophysiology, prevention, management, and advancing therapy for different patient populations with metabolic health issues, including obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, and other conditions associated with insulin resistance and inflammation. Articles published in the journal will encompass original research with a broad biomedical approach from bench to bedside, including basic research and clinical case studies. In addition, the journal will feature review articles, perspectives, case studies, case reports and editorials to provide comprehensive coverage and critical insights into the field. The content will be of interest to an academic and clinician-based audience, including medical practitioners, clinical educators, dietitians, nutritionists, nurse practitioners, pharmacists, and other healthcare professionals involved in the study and management of metabolic health disorders.